Finance

Beta
Lists
532300:BOM
Wockhardt Ltd
₹1,934.95
+0.41%
(+7.95) 1D
Jun 12, 3:57:58 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532300...
Open
₹1,948.15
High
₹1,976.05
Low
₹1,918.25
Mkt. cap
315.46B
Avg. vol.
262.78K
Volume
110.47K
P/E ratio
147.71
52-wk high
₹2,420.00
52-wk low
₹1,086.80
EPS
₹13.10
Shares outstanding
110.69M
No. of employees
2K
Open
₹1,948.15
High
₹1,976.05
Low
₹1,918.25
Mkt. cap
315.46B
Avg. vol.
262.78K
Volume
110.47K
P/E ratio
147.71
52-wk high
₹2,420.00
52-wk low
₹1,086.80
EPS
₹13.10
Shares outstanding
110.69M
No. of employees
2K
News stories
From sources across the web
Profile
Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients. The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. Wikipedia
About Wockhardt Ltd
CEOMurtaza Khorakiwala
Employees2.3K
Founded1967
Headquarters-
SectorPharmaceutical industry
Websitewockhardt.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
7.38B
7.82B
8.88B
9.65B
Cost of goods sold
2.64B
2.33B
3.17B
3.18B
Cost of revenue
2.64B
2.33B
3.17B
3.18B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.71B
1.86B
1.81B
1.87B
Operating expense
4.29B
4.42B
4.63B
5.04B
Total operating expenses
6.93B
6.75B
7.80B
8.22B
Operating income
450.00M
1.07B
1.08B
1.43B
Other non operating income
200.00M
210.00M
250.00M
450.00M
EBT including unusual items
-1.09B
910.00M
670.00M
1.89B
EBT excluding unusual items
-120.00M
910.00M
770.00M
1.67B
Income tax expense
-10.00M
90.00M
60.00M
250.00M
Effective tax rate
0.92%
9.89%
8.96%
13.23%
Other operating expenses
2.02B
2.03B
2.17B
2.64B
Net income
-900.00M
780.00M
590.00M
1.66B
Net profit margin
-12.20%
9.97%
6.64%
17.20%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-480.00M
-550.00M
-600.00M
-500.00M
Net interest expenses
-480.00M
-550.00M
-600.00M
-500.00M
Depreciation and amortization charges
560.00M
530.00M
650.00M
530.00M
EBITDA
842.50M
1.62B
1.47B
2.00B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer